The Latest Breaking News from Obesity

Ozempic and other GLP-1 drugs have proved to be revolutionary in managing the epidemic of obesity, treating diabetes, and somewhat reducing the risk of many chronic diseases. Studies are now proving its efficacy in improving brain health. According to a new study published in the journal Alzheimer's Dementia, Semaglutide, the…

The medicines regulator has also urged medics to warn patients of side effects.

The proposals came from the Lords’ Food, Diet and Obesity Committee.

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

The study found associations between a mother's history of eating disorders and pre-pregnancy body mass index (BMI) higher than the normal weight range to most of the nine psychiatric diagnoses examined in the offspring.

Reducing the rate of overweight and obesity in Australian kids and teenagers by five per cent could save them more than $7 billion in lifelong health costs.

LABOUR are urging the SNP to mimic their plans to tackle obesity with weight-loss jabs.

Mexico's new regulations ban junk food in schools to combat childhood obesity, facing challenges in enforcement and infrastructure.

UK health secretary says people will not be ‘involuntarily jabbed’ but that medications could be ‘gamechanging’

The growing – and sometimes secret – use of drugs containing semaglutide has had a huge impact on how we live … but where will it end?

Shifting blame to the victims of economic policy is an old trick by politicians. Now they’re using obesity to tackle joblessness